P-011: A randomized phase 2 study of modakafusp alfa (TAK-573) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with a pilot diversity, equity, and inclusion (DEI) strategy
Titel:
P-011: A randomized phase 2 study of modakafusp alfa (TAK-573) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with a pilot diversity, equity, and inclusion (DEI) strategy
Auteur:
Kaufman, Jonathan Atrash, Shebli Benson, Don Holstein, Sarah Nadeem, Omar Biran, Noa Suryanarayan, Kaveri Liu, Yuyin Robinson, LaShell Correa, Karen Enwemadu, Victoria Parot, Xavier Vogl, Dan